The U.S. Food and Drug Administration (FDA) has issued a recall for Dynacare baby powder, which was sold in 35 states, due to ...

A type of baby powder that was distributed in 35 states, as well as sold online on Amazon, has been recalled over possible ...

The fate of Johnson & Johnson’s latest push to use bankruptcy courts to end thousands of cancer lawsuits tied to its iconic baby powder now hinges on a high-stakes trial in January. After months ...

I am hoping you will publish this piece I’ve written to amplify my voice to give hope to the hundreds of women in Pennsylvania and the tens of thousands of women across the country who were ...

Johnson & Johnson has agreed to pay a $700 million settlement to resolve a probe by 42 US states and Washington, DC. The inquiry examined the marketing of their baby powder and other talc-based ...

J&J Must Pay $15 Million to Man Who Says Its Talc Caused His Cancer, Jury Finds By Brendan Pierson (Reuters) -Johnson & Johnson must pay $15 million to a Connecticut man who alleges that he ...

[iStocphoto] A lobby group has moved to court seeking a ban on the use of Johnson & Johnson baby powder over claims it causes cancer as the battle over the use of the American-based firm's product ...

Johnson & Johnson (JNJ) is taking a controversial legal argument to court for a third time in hopes of containing a barrage of lawsuits alleging its baby powder caused cancer, but it also faces ...

The Bombay High Court on Wednesday ordered fresh testing of Johnson & Johnson baby powder samples and permitted the company to manufacture the product but to not sell it, as per the Maharashtra ...

On Oct. 28, the FDA announced that Dynacare, a baby powder sold by the Dynarex Corporation, was recalled because of a “Potential Metal or Chemical Contaminant.” Related: Johnson and Johnson ...

This is not the first time baby powder has been recalled over asbestos concerns. In 2019, Johnson & Johnson recalled about 33,000 bottles of Johnson’s Baby Powder after the FDA found traces of ...

Oct 15 (Reuters) - Johnson & Johnson (JNJ.N), opens new tab must pay $15 million to a Connecticut man who alleges that he developed mesothelioma, a rare form of cancer, as a result of using the ...